FDA Class II: Phenylephrine Injection Recalled for Manufacturing Deviations
Denver Solutions is recalling 325,300 units of Phenylephrine HCl injection due to Current Good Manufacturing Practice deviations. The product was distributed nationwide, including to government facilities.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for manufacturing process deviations without reported illnesses or injuries. The hazard is theoretical, and the firm voluntarily corrected the issue, placing this in the Moderate category per the voluntary precautionary recall criterion.
Plain-English summary
Denver Solutions, LLC (doing business as Leiters Health) is recalling approximately 325,300 units of Phenylephrine HCl 1mg per 10mL injectable solution in 10 mL syringes. This is a prescription-only medication. The recall affects 17 lot numbers with expiration dates from March 5, 2023, through July 15, 2023.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing. The product was distributed nationwide within the United States, including to government facilities and the Department of Veterans Affairs. The firm voluntarily initiated the recall, which was completed as of January 11, 2024.
The FDA classified this as a Class II recall, indicating that while the product may pose a health risk, serious adverse health consequences or death is not likely to result.
The recalled product
- Product
- Phenylephrine HCl 1mg per 10mL (100 mcg/mL) 10 mL syringes, Rx only, Leiters 13796 Compark Blvd Englewood CO 80112, NDC 71449-001-15
- Manufacturer
- Denver Solutions, LLC DBA Leiters Health
- Category
- Drug — Injectable / Prescription
- Affected units
- 325,300
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: 2230895
- Exp. Date 3/5/2023
- 2230911
- Exp. Date 3/11/2023
- 2230913
- Exp. Date 3/18/2023
- 2230994
- Exp. Date 3/27/2023
- 2231006
- Exp. Date 4/1/2023
- 2231109
- Exp. Date 4/19/2023
- 2231126
- Exp. Date 5/6/2023
- 2231134
- Exp. Date 5/10/2023
- 2231140
- Exp. Date 5/14/2023
- 2231142
- Exp. Date 5/20/2023
Distribution
Part of a larger recall action
This product is one of 4 recalled by Denver Solutions, LLC DBA Leiters Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Denver Solutions, LLC DBA Leiters Health
See all →- SevereDexmedetomidine HCl Syringes Recalled for Potential Sterility Issue
FDA (Drugs) · 2025-04-30
- SevereKetamine HCl Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2025-04-30
- SeverePHENYLephrine HCl Injection Syringes Recalled for Lack of Sterility
FDA (Drugs) · 2025-04-30
- HighGlycopyrrolate 1mg/5mL Syringes Recalled for Sterility Risk
FDA (Drugs) · 2025-04-30
- SevereRocuronium Bromide Syringes Recalled Due to Sterility Assurance Risk
FDA (Drugs) · 2025-04-30
Same hazard · manufacturing defect
See all →- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-09-09
- HighSun Pharmaceutical Recalls Carbamazepine Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2026-08-26
- HighKnee Prosthesis Trial Recall for Manufacturing Defect
FDA (Devices) · 2026-08-12
- HighUSTAR II Knee System Hinge Box Trial Recall
FDA (Devices) · 2026-08-12
- HighU2 Total Knee System Femoral Valgus Adaptor Recall
FDA (Devices) · 2026-08-12